Neogen Chemicals Other Announcement
A HUF of a director of Neogen's wholly owned subsidiary sold 2,361 shares on 5-6 November 2026. Sale consideration totals about ₹0.59 crore.
- Value
- ₹0.59 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
8 announcements with these filters
A HUF of a director of Neogen's wholly owned subsidiary sold 2,361 shares on 5-6 November 2026. Sale consideration totals about ₹0.59 crore.
Neogen reports no deviation in QIP fund utilisation for the quarter ended September 30, 2026. This is a periodic utilisation report, not a new transaction.
Neogen Chemicals Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under Regulation 31(1)(b) of SEBI LODR.
Neogen Chemicals Ltd has submitted its quarterly shareholding pattern disclosure as per SEBI regulations. This routine filing details the current equity distribution among promoters and public shareholders.
Neogen Chemicals filed its quarterly Security Cover Certificate for NCDs as of June 30, 2026, confirming compliance with SEBI Regulations regarding debt security maintenance.
Axis Mutual Fund sold a 1.46% stake in Neogen Chemicals via open market transactions. Its holding reduced to 4.04%, reflecting institutional profit-booking or portfolio rebalancing.
Neogen Chemicals submitted its Annual Secretarial Compliance Report for FY2026. The document details historical non-compliance regarding director re-appointments and confirms that all associated exchange fines were paid.
Neogen Chemicals received an unmodified audit opinion for its FY2026 financial results. This confirmation from auditors validates the company's reported financial integrity for shareholders.